(R) -CR8
(R) -CR8 is a potent and selective CDK inhibitor.A delayed systemic post-LFP administration at 3 hours of CR8--a potent second-generation cyclin-dependent kinase (CDK) inhibitor.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
431.53
Molecular Formula
C24H29N7O
Notes
Research use only, not for human use.
Receptor
CDK
CAS Number
294646-77-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7095700 Inquire
Recombinant Emballonura alecto NADH-ubiquinone oxidoreductase chain 1 (MT-ND1), partial
Ask
View Details